A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza
Public ClinicalTrials.gov record NCT03336619. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Trial to evaluate efficacy and safety of nitazoxanide (NTZ) in the treatment of uncomplicated influenza.
Study identification
- NCT ID
- NCT03336619
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,030 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 17, 2018 (Actual)
- Primary completion
- Apr 17, 2019 (Actual)
- Completion
- Apr 17, 2019 (Actual)
- Last update posted
- Jun 28, 2022
2018 – 2019
United States locations
- U.S. sites
- 34
- U.S. states
- 16
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanguard Study Site | Alabaster | Alabama | 35007 | — |
| Vanguard Study Site | Birmingham | Alabama | 35235 | — |
| Vanguard Study Site | Birmingham | Alabama | 35242 | — |
| Vanguard Study Site | Hoover | Alabama | 35216 | — |
| Vanguard Study Site | Pelham | Alabama | 35124 | — |
| Vanguard Study Site | Goodyear | Arizona | 85338 | — |
| Vanguard Study Site | Tolleson | Arizona | 85353 | — |
| Vanguard Study Site | Hot Springs | Arkansas | 71913 | — |
| Vanguard Study Site | Anaheim | California | 92805 | — |
| Vanguard Study Site | Westminster | California | 92683 | — |
| Vanguard Study Site | Lauderdale Lakes | Florida | 33319 | — |
| Vanguard Study Site | Orlando | Florida | 32806 | — |
| Vanguard Study Site | Valparaiso | Indiana | 46383 | — |
| Vanguard Study Site | New Orleans | Louisiana | 70124 | — |
| Vanguard Study Site | St Louis | Missouri | 63141 | — |
| Vanguard Study Site | Missoula | Montana | 59808 | — |
| Vanguard Study Site | Brooklyn | New York | 11229 | — |
| Vanguard Study Site | Cincinnati | Ohio | 45215 | — |
| Vanguard Study Site | Columbus | Ohio | 43214 | — |
| Vanguard Study Site | Dayton | Ohio | 45424 | — |
| Vanguard Study Site | Medford | Oregon | 97504 | — |
| Vanguard Study Site | Rapid City | South Dakota | 57702 | — |
| Vanguard Study Site | Jackson | Tennessee | 38305 | — |
| Vanguard Study Site | Smyrna | Tennessee | 37167 | — |
| Vanguard Study Site | Austin | Texas | 78735 | — |
| Vanguard Study Site | Carrollton | Texas | 75010 | — |
| Vanguard Study Site | Dallas | Texas | 75204 | — |
| Vanguard Study Site | Dallas | Texas | 75230 | — |
| Vanguard Study Site | Fort Worth | Texas | 76107 | — |
| Vanguard Study Site | Houston | Texas | 77058 | — |
| Vanguard Study Site | Pharr | Texas | 78577 | — |
| Vanguard Study Site | Plano | Texas | 75024 | — |
| Vanguard Study Site | Plano | Texas | 75093 | — |
| Vanguard Study Site | St. George | Utah | 84790 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03336619, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2022 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03336619 live on ClinicalTrials.gov.